M&T Bank
DCPH

M&T Bank’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

M&T Bank’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,788
Closed -$230K – 1631
2021
Q3 		$230K Sell
6,788
-2
-0% -$64 ﹤0.01% 1373
2021
Q2 		$249K Hold
6,790
– – ﹤0.01% 1356
2021
Q1 		$305K Buy
6,790
+617
+10% +$28.7K ﹤0.01% 1226
2020
Q4 		$352K Buy
6,173
+88
+1% +$5.22K ﹤0.01% 1250
2020
Q3 		$312K Buy
6,085
+1,214
+25% +$59.5K ﹤0.01% 1218
2020
Q2 		$291K Buy
+4,871
New +$261K ﹤0.01% 1206
2020
Q1 		– Sell
-4,429
Closed -$276K – 1718
2019
Q4 		$276K Buy
+4,429
New +$210K ﹤0.01% 1126

Other funds holding DCPH

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

M&T Bank's DCPH Position: Q4 2021 in Review

M&T Bank sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2021, closing a stake of 6,788 shares — an estimated $230K sold.

M&T Bank first reported a position in DCPH in Q4 2019 and held it in 7 quarters. The position peaked at $352K in Q4 2020. 140 funds tracked by Wall St. Rank hold DCPH as of Q4 2021.

  • M&T Bank reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • M&T Bank sold 6,788 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $230K.
  • M&T Bank first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 7 quarters.
  • M&T Bank's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $352K in Q4 2020.
  • 140 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on M&T Bank's 13F filing for Q4 2021, filed 7 Feb 2022.